Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Spironolactone effectively treats female acne with few side effects.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Women with PCOS may be more likely to have gum disease than healthy women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

PCOS can cause unusual symptoms like late puberty and enlarged clitoris, making diagnosis difficult.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Skin symptoms can indicate endocrine disorders and have various treatments.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.